Add BrightSurf on Google Email

Science News for November 27, 2000


University of Pittsburgh reports best gene delivery to date of protein missing in Duchenne Muscular Dystrophy

Scientists at the University of Pittsburgh have engineered a novel gene therapy to treat Duchenne Muscular Dystrophy (DMD), a genetic disorder causing progressive muscle weakening and death. The mini-gene AAV vector effectively delivers functional dystrophin protein, correcting muscle dysfunction and degeneration.

SourceUniversity of Pittsburgh Medical Center·JournalProceedings of the National Academy of Sciences·DateNov 27, 2000

Fogarty International Center announces new awards under International Training And Research In Population And Health Program

The Fogarty International Center has awarded $9 million to U.S. universities to support international training and research in population-related sciences, focusing on reproductive processes, contraceptive development, and demographic studies. This funding will help address global population growth trends and health disparities in deve...

HIV drug leaves key part of immune system vulnerable

Researchers at Ohio State University found that a commonly used HIV drug, AZT, does not prevent virus-related damage to the thymus in young cats infected with FIV. The study suggests that antiviral therapy may need to be combined with other treatments to restore thymic function and protect against immune system problems.

SourceOhio State University·JournalAntimicrobial Agents and Chemotherapy·DateNov 27, 2000

Oral contraceptive use does not affect bone mass

A long-term study of 62 white female participants aged 12-20 found that oral contraceptive pill (OCP) use did not impact their peak bone mass or hip bone mineral density, contrary to theoretical concerns. The findings are significant as they address the needs of young women who are concerned about body changes during adolescence.

SourcePenn State·JournalFertility and Sterility·DateNov 27, 2000